Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
Liting Xue(Simcere Pharmaceutical (China)), Wenqing Yang(Simcere Pharmaceutical (China))
Cited by 21
Related Papers
THUMPD2 catalyzes the <i>N2</i>-methylation of U6 snRNA of the spliceosome catalytic center and regulates pre-mRNA splicing and retinal degeneration
|Nucleic Acids Research|2024|11
THUMPD2 catalyzes <i>N</i> <sup> <i>2</i> </sup> -methylation on the spliceosome catalytic center of U6 snRNA and regulates pre-mRNA splicing
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0